“FEATURES OF THE PHARMACOEPIDEMIOLOGICAL DESCRIPTION OF POST-COVID-19 AHAB IN WOMEN”. The Conference Hub, Aug. 2025, pp. 53-56, https://theconferencehub.com/index.php/tch/article/view/429.